No abstract
Our previous studies revealed that recombinant human CYP3A4 converted 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D 3 (O2C3), which was a more potent binder to vitamin D receptor (VDR) than the natural hormone, 1α,25-dihydroxyvitamin D 3 (1α,25(OH) 2 D 3 , 1), to 1α,2α,25-trihydroxyvitamin D 3 (2). Here, we synthesized 2 using the Trost Pd-mediated coupling reaction between an A-ring precursor and a CD-ring bromoolefin and evaluated its preliminary biological activity. We found that metabolite 2 from O2C3 was still active as a VDR ligand while maintaining human VDR binding affinity (27 1-4) Actually, 1 and several synthetic analogs of 1 have been used clinically in the treatment of bone diseases, secondary hyperparathyroidism, psoriasis, and osteoporosis.1,5) Although 1 is inactivated by CYP24A1-dependent catabolism via C-24 hydroxylation to calcitroic acid for excretion from the body, 1) it was found that some 2α-substituted active vitamin D analogs were highly resistant to CYP24A1, for example, the k cat /K m value of 2α-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D 3 (O2C3), which showed 1.8-times greater binding affinity for vitamin D receptor (VDR) than 1, [6][7][8][9][10] was only 3% of that for 1. 11) CYP24A1 is the specific enzyme induced by the VDR-ligand (1 or its analog) complex in the target tissue and inactivates 1 and its analogs; therefore, CYP24A1-resistant ligands would have long-term biological effects on the target tissues.12) On the other hand, CYP3A4 is a broad-spectrum drug-metabolizing P450 enzyme, 13) but 1 and its analog 2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D 3 (O1C3) are not primary substrates for CYP3A4.12) Recently, however, we demonstrated that O2C3 was metabolized by CYP3A4 and converted to 1α,2α,25-trihydroxyvitamin D 3 12) (2, Fig. 1). Its 2β-isomer (4) is a known compound and shows potent 1α,25(OH) 2 D 3 -like activities, 14) and we report here the synthesis of a new 2α-hydroxylated analog 2 using the Trost Pd-mediated coupling reaction between an A-ring precursor 12 and a CD-ring bromoolefin 13 to evaluate its preliminary biological activity. 15-18)The A-ring precursor 12 for Trost coupling was prepared from the known epoxide 5 19) in 11 steps (Chart 1). Briefly, treatment of 5 with p-methoxybenzyl alkoxide with heating gave methyl 3-O-(p-methoxybenzyl) altropyranoside 6, which had the 2α-hydorxy group (steroidal numbering) required in target molecule 2. After 2-O-silylation, the p-methoxybenzyl (PMB) protecting group was removed by 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) to give 7, and the methoxymethyl (MOM) group was introduced instead for the next bromination reaction using N-bromosuccinimide (NBS). NBS treatment for the resulting O-MOM-protected bezylidene acetal gave bromide 8. Activated Zn-reduction in the presence of NaBH 3 CN produced alcohol 9, which was converted to epoxide 10 via tosylation followed by tetrabutylammonium fluoride (TBAF) treatment. Trimethylsilyl (TMS)-ethynylation of 10 afforded enyne 11, and subsequent solvolysis in K 2 CO 3 -MeOH and O-...
Review on repeatability of measurement value and the optimum seasons of the one-meter-depth temperature survey toward an ideal investigation method for groundwater-vein streams 竹内篤雄 Atsuo TAKEUCHI/株式会社G&Mリサーチ G&M Research Co. Ltd 渡辺知恵子 Chieko WATANABE/元株式会社神陽技研 former Shin' you Geo-engineering Co. Ltd 大谷沙織 Saori OHYA/株式会社G&Mリサーチ G&M Research Co. Ltd 山田 晃 Akira YAMADA/川崎地質株式会社 Kawasaki Geological Engineering Co. Ltd キーワード:1m深地温,水ミチ,再現性,実施時期 Key words:1m-depth temperature, groundwater-vein streams, repeatability, optimum seasons 図−1 平常1m深地温と流動地下水温の季節変化 (石川県繩又地すべり・兵庫県宮神地すべりの 例) (Takeuchi(1 9 8 0) ) 報告
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.